broad experience as Chief Executive Officer, finance & administrative Director and Business Consultant in various sectors and especially in fast growing and changing environments. profound and practical business knowledge (25 years in finance, Corporate Finance, hrm, tax & legal, investor relations, Business Development and Operations), critical in thinking, thorough, with strong commitment, good people management skills and hands-on. summary of my professional achievements : • realized growth (revenues & personnel) of a local start-up company towards a global listed group; • realized value creation (e.g. from local academic Research to Clinical Development in europe & us); • closed strategic corporate partnership transactions & managed several acquisitions; • closed significant financing rounds (ipo, private placements and grants) despite tough (market) conditions; • designed and lead corporate transition/change processes; • realized severe cost reduction while optimizing allocation of limited resources; • implemented good corporate governance practices; • improved business insight and facilitated fact-based operational & strategic decision making.
Director / CEO / CFO for innovative companies
Since January 2011
advising innovative fast growing/changing companies on key strategic, Corporate Finance and financial matters. Director of s.i.s.e. sa - platform for Cell therapy. Advising innovative fast growing/changing companies on key strategic, corporate finance and financial matters. Director of S.I.S.E. sa - Platform for Cell Therapy.
CEO & CFOJanuary 2006 --- January 2010
Chief Executive Officer (2008-2010) chief financial officer (2006-2007) accomplishments and results achieved • moved two pre-clinical anti-Cancer drug candidates to clinical Phase I, one in the us (ind-FDA) & one in europe (impd-emea); • closed strategic alliance for late Preclinical compound worth $ 31m with us based Pharmaceutical company; • closed several financing rounds (raised € 8m - private placements and grants) for early-stage pipeline; • realized severe cost reduction (net result + 45%) while optimizing allocation of resources and starting 2 Clinical trials. duties and responsibilities • lead the transition from a University spin-off towards a professional biotech company with limited resources; • made Analysis & strategic plan for Cancer Drug Development and Discovery activities; defined & managed priorities in line with pharma industry, oncology experts’ and investors’ expectations (value creation); strictly coordinated & monitored progress in development (milestones); • negotiated & coordinated all m&a and financing transactions, incl. Due Diligence work; • implemented good corporate governance practices; • reported transparent information to bod and private & public stakeholders, and managed expectations.
Sarbanes-Oxley & Compliance OfficerJanuary 2004 --- January 2006
. accomplishments and results achieved • improved Compliance of all subsidiaries worldwide with internal (ing group) and external laws and regulations, including sarbanes-oxley, operational & information Risk Management, financial economic crime, …
Head of Finance DivisionJanuary 2001 --- January 2003
. accomplishments and results achieved • designed and lead change process from local statutory Accounting towards a professional Finance department with pro-active & international management reporting per business segment and including a treasury department; • re-defined Business Processes and streamlined policies & analytical structure according to international guidelines to prepare e&y belgium for e&y international global profit sharing; • presented results to the local executive committee and to e&y international.
Group Finance & Admin. DirectorJanuary 1997 --- January 2001
. accomplishments and results achieved • managed administrative & financial growth (revenues & personnel) of a start-up it company towards a global listed group, through several critical stages : • all financing rounds since incorporation (raised > $ 135m); • six acquisitions (both in the us & in europe); • ipo of a global high tech Software security company on the easdaq stock exchange - carried out successfully in june 2000 despite crash of tech markets. preparation of information for the beauty contest to select the lead bank (ing, london); Due Diligence; prospectus writing, business plan & Business Strategy definition; new reporting & Communication rules of a public company; investor relations; • managed all administrative/legal/hrm activities; responsible for financial analyses, treasury, Due Diligence exercises related to m&a and financing transactions, business plans, valuations, group-wide management reporting system (usgaap) and policies & procedures; • managed integration work to align the acquired companies, to enable tracking & analyzing of kpi’s in the various business units and to make the group benefit from synergies (to boost revenues and to cut costs).
Financial ControllerJanuary 1991 --- January 1996
• prepared consolidated group management information & detailed audit reports (profitability studies, audit of current account of managers/founders, analyses & re-Negotiation of bank debts & related guarantees, forecasts, business plan) for the bod, the audit committee and the shareholders to enable the bod to take appropriate business decisions; • analyzed profitability of projects, subsidiary performance & acquisition targets and the effect on profitability of different scenarios to restructure the business; recommended & implemented cost saving measures & improvements (optimized fiscal structure, re-organized & reduced number of offices in belgium, closed down the office in the us, …); analyzed the return on Investments for projects; recommended which Investments were preferably to be sold (mbo of construction company), which activities to be terminated (project development) & where to focus commercial activities; • developed recommendations and implemented decisions taken to restructure the business; • (re)-negotiated bank loans & credit facilities, designed & implemented cash pooling; • developed and analyzed business plans for/from new investors/business partners; • Secretary to the bod.
Finance Department Assistant for 5 consecutive summersJanuary 1981 --- January 1985
LinkedIn Assessment :
Masters in Applied Economics from U.F.S.I.A. (University of Antwerp) in 1986
Area / Region